MedTrace Logo

Colorectal Cancer Screening With Improved Shared Decision Making

NCT01519999 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 206721

Last updated 2019-02-04

No results posted yet for this study

Summary

The purpose of this study is to increase colorectal cancer screening by implementing a community-wide shared decision-making (SDM) intervention, which embeds shared decision making within clinical practice and also uses an extensive community engagement campaign. The investigators hypothesize that colorectal cancer screening adherence will be higher in the intervention group (participating communities) compared to the usual care control group (non-participating comparison communities).

Conditions

  • Colorectal Cancer Screening
  • Shared Decision Making

Interventions

BEHAVIORAL

Shared Decision Making for Colorectal Cancer Screening

Age-eligible adults in the intervention communities will be exposed to the shared decision-making intervention when they are seen in the primary care clinics (N=all patients 50-75 years seen during the study period who are non-adherent to CRCS recommendation). Additionally, among patients with primary care visits scheduled one week or more before the visit, they will be randomized to receive either a mailed decision aid booklet or an informational flyer on shared decision making and CRCS prior to the visit. Patients with primary care visits scheduled less than one week prior to the visit will not be mailed materials in advance. The effect of the pre-visit materials on referral to SDM session and CRCS adherence between these groups will be compared. They will also be exposed to shared decision-making tools and resources available through the community-wide intervention activities.

Sponsors & Collaborators

  • Allina Health System

    collaborator OTHER

  • Blue Cross Blue Shield

    collaborator OTHER

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Resa M Jones, MPH, PhD · Virginia Commonwealth University and Temple University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2017-07-18
Completion
2017-07-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01519999 on ClinicalTrials.gov